Parkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.

Simple item page
dc.contributor.authorSarasombath, Pichaya
dc.contributor.authorSumida, Kenneth N. M.
dc.contributor.authorKaku, David A
dc.date.accessioned2016-10-25T23:04:19Z
dc.date.available2016-10-25T23:04:19Z
dc.date.issued2002-03
dc.description.abstractA 79 year-old man was treated with Interferon alpha for chronic myelogenous leukemia and developed severe parkinsonism that resolved after Interferon alpha was stopped. Carbidopa-levodopa was associated with early improvement, but discontinuation did not result in worsening of the parkinsonism.
dc.identifier.issn0017-8594
dc.identifier.pubmed11965836
dc.identifier.urihttp://hdl.handle.net/10524/53716
dc.language.isoeng
dc.subject.meshAged
dc.subject.meshAntineoplastic Agents/administration & dosage/adverse effects
dc.subject.meshAntiparkinson Agents/administration & dosage
dc.subject.meshCarbidopa/administration & dosage
dc.subject.meshHumans
dc.subject.meshInterferon-alpha/administration & dosage/adverse effects
dc.subject.meshLeukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
dc.subject.meshLevodopa/administration & dosage
dc.subject.meshMale
dc.subject.meshParkinson Disease, Secondary/chemically induced/drug therapy
dc.subject.meshRecombinant Proteins
dc.subject.meshTreatment Outcome
dc.titleParkinsonism associated with interferon alpha therapy for chronic myelogenous leukemia.
dc.typeArticle
dc.type.dcmiText
prism.number3
prism.pagerange48, 57
prism.publicationnameHawaii Medical Journal
prism.volume61

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2002-03p48-57.pdf
Size:
226.54 KB
Format:
Adobe Portable Document Format
Download

Collections

Hawaii Medical Journal Articles For 2002